Hyperfine (NASDAQ: HYPR) net income
Hyperfine reported a net loss of $35.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $40.7m. Earnings per share were −$0.43.
Hyperfine's best year of the last 6 was fiscal 2020. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$35.6m | — | −262.3% | −$0.43 |
| 2024 | −$40.7m | — | −315.9% | −$0.56 |
| 2023 | −$44.2m | — | −401.0% | −$0.62 |
| 2022 | −$44.2m | — | −649.2% | −$1.04 |
| 2021 | −$64.9m | — | −4,335.0% | −$17.57 |
| 2020 | −$23.4m | — | −7,968.4% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Hyperfine net income compared with its sector
By net income for its latest fiscal year, Hyperfine ranks 229th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Hyperfine, −262.3%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 227th | AN2 Therapeutics | −$35.2m | — |
| 228th | Immunocore | −$35.5m | −8.9% |
| 229th | Hyperfine | −$35.6m | −262.3% |
| 230th | Canton Strategic | −$35.9m | — |
| 231st | Context Therapeutics | −$36.1m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Hyperfine
- How much did Hyperfine earn in fiscal 2025?
- Hyperfine reported a net loss of $35.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $40.7m.
- What are the earnings per share of Hyperfine?
- They were −$0.43 in fiscal 2025, compared with −$0.56 in fiscal 2024.
- Where does Hyperfine rank in its sector by net income?
- It ranks 229th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Hyperfine come from?
- From the annual report (Form 10-K) that Hyperfine files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Hyperfine files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Hyperfine: the Hyperfine page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.